Device Trial Radar · NCT02476318
A Study to Evaluate the Safety and Performance of ArterX™ Vascular Sealant in Sealing Synthetic Arterial Grafts
Last checked: Nov 19, 2026Latest source record: Jun 19, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
32
Actual
Start
Jun 2007
Primary completion
Aug 2007
Study completion Nov 2007
Sponsor
- Lead sponsor
- Tenaxis Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 19, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A prospective, multi-center study to evaluate the safety and performance outcomes of the ArterX Vascular Sealant when used for prophylactic sealing of suture lines at the anastomosis between native vessel and synthetic vascular grafts.
Conditions
- Vascular Disease
Interventions
ArterX Vascular SealantDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of anastomoses with immediate sealing of the suture lineTime frame: Intraoperative
Locations
3 sites in 1 country. Site status is shown where the registry gives one.
Klinikum der Universitat zu Koln
Cologne, Germany
Krankenhaus Dresden Friedrichstadt
Dresden, Germany
Chirugische Uni Klinikum
Ulm, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.